Anti–Vascular Endothelial Growth Factor Drugs Compared With Panretinal Photocoagulation for the Treatment of Proliferative Diabetic Retinopathy:A Cost-Effectiveness Analysis

Walton, Matthew orcid.org/0000-0003-1932-3689, Bojke, Laura orcid.org/0000-0001-7921-9109, Simmonds, Mark orcid.org/0000-0002-1999-8515 et al. (10 more authors) (2024) Anti–Vascular Endothelial Growth Factor Drugs Compared With Panretinal Photocoagulation for the Treatment of Proliferative Diabetic Retinopathy:A Cost-Effectiveness Analysis. Value in Health. pp. 907-917. ISSN 1524-4733

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© 2024, International Society for Pharmacoeconomics and Outcomes Research, Inc.

Keywords: aflibercept,anti-VEGF,diabetic retinopathy,discrete event simulation,IPD meta-analysis,ranibizumab
Dates:
  • Published: 1 July 2024
  • Published (online): 22 April 2024
  • Accepted: 14 March 2024
  • Submitted: 6 October 2023
Institution: The University of York
Academic Units: The University of York > Faculty of Social Sciences (York) > Centre for Reviews and Dissemination (York)
The University of York > Faculty of Social Sciences (York) > Centre for Health Economics (York)
The University of York > Faculty of Sciences (York) > Health Sciences (York)
Depositing User: Pure (York)
Date Deposited: 15 Mar 2024 12:10
Last Modified: 22 Feb 2025 00:07
Published Version: https://doi.org/10.1016/j.jval.2024.03.007
Status: Published
Refereed: Yes
Identification Number: 10.1016/j.jval.2024.03.007
Related URLs:
Open Archives Initiative ID (OAI ID):

Download

Filename: PIIS1098301524001220.pdf

Description: Anti–Vascular Endothelial Growth Factor Drugs Compared With Panretinal Photocoagulation for the Treatment of Proliferative Diabetic Retinopathy: A Cost-Effectiveness Analysis

Licence: CC-BY 2.5

Export

Statistics